Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Operations (Unaudited)

v3.22.2.2
Condensed Consolidated Interim Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Expenses    
Research and development $ 3,171 $ 3,793
General and administrative 1,475 2,178
Operating Expenses (4,646) (5,971)
Other income    
Foreign exchange 11 4
Interest, net 39 1
Other (loss) income 50 5
Net loss for the period (4,596) (5,966)
Computation of basic loss per share    
Net loss (4,596) (5,966)
Series A Preferred cash dividend (2) (2)
Net loss for the period attributable to common stockholders $ (4,960) $ (8,430)
Basic and fully diluted loss per share $ (0.07) $ (0.25)
Basic and fully diluted weighted average number of shares 73,205,000 34,281,000
Preferred Stock Series C    
Computation of basic loss per share    
Preferred stock dividend $ (362) $ (2,462)